Rockin Robin SongFlying The Web For News.
RobinPost Logo Amazon Prime Deals

feed-image RSS




Science Daily Reports

Trusted reliable news sources from around the web. We offer special news reports, topic news videos, and related content stories. Truly a birds eye view on news.
Penumbra shares soared 12% to $351.46 on Thursday. Boston Scientific stock slumped 4.1%, making it one of the worst performers in the S&P 500. Boston Scientific was a Barron’s stock pick in October.
Original Image Link
Source:www.msn.com

Boston Scientific is spending $14.5 billion in cash and stock to buy Penumbra, another medical-device maker that makes products used in minimally invasive procedures to treat conditions such as blood ...
Original Image Link
Source:www.msn.com

Boston Scientific has agreed to acquire Penumbra in a cash-and-stock deal worth $14.5 billion. The addition of Penumbra, which makes mechanical thrombectomy products for vascular procedures, expands ...
Original Image Link
Source:www.msn.com

Boston Scientific said on Thursday it will buy Penumbra in a deal valued at about $14.5 billion to expand its vascular pipeline. The deal values Penumbra at $374 per share, a premium of about 19.3% to ...
Original Image Link
Source:www.msn.com

Boston Scientific is spending $14.5 billion in cash and stock to buy Penumbra, another medical-device maker that makes products used in minimally invasive procedures to treat conditions such as blood ...
Original Image Link
Source:www.msn.com

Boston Scientific has long used mergers and acquisitions to fuel growth. This deal appears to be its largest since its acquisition of Arden Hills pacemaker company Guidant in 2006 for $27B.
Original Image Link
Source:www.startribune.com


Related Product Search/Búsqueda de productos relacionados

Amazon Logo